Erythropoietin is a glycoprotein hormone responsible for the regulation of red blood cell production. This hormone triggers the proliferation, differentiation and maturation of bone marrow erythroid precursors into functional erythrocytes. The Global Erythropoietin Market was valued around US$ 6.7 Billion in 2015. This market is poised to decline initially due to patent expiry of biologic erythropoietin drugs and decline in their sales owing to the entry of biosimilars. Eventually, the Global Erythropoietin Market will start to witness a positive growth as the penetration of biosimilar versions of the erythropoietin drugs will increase. Moreover, this market will be driven by increasing number of patients suffering from anemia induced due to cancer, HIV, and renal diseases treatment, and increasing commercialization of erythropoietin biosimilars by numerous pharmaceutical companies all across the world.
According to our report, “EPO Biosimilars - The Future of Erythropoietin Market”, in the wake of the above developments the Global Erythropoietin Market is expected to grow at a meager CAGR of less than 1% from 2015 – 2022. The market segmentations by type, by drug and by application have been mentioned in the report. Based on geography, the report divides the market into the US, Europe, and Asia-Pacific. Various drivers and challenges have been listed down that affect the Global Erythropoietin Market. A detailed analysis of the clinical pipeline of erythropoietin has also been carried out in the report.
The report also covers the key players of the Global Erythropoietin Market. For each player, a brief business overview and key financials has been provided. The product portfolio and recent developments of each player have also been listed down. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the Global Erythropoietin Market.
Some of the key findings of the report are:
· Erythropoietin Biosimilars Open Array of Opportunity for Market Growth